Hepcidin and the iron enigma in HCV infection

References

• Steinbicker AU, Muckenthaler MU. Out of balance--systemic iron homeostasis in iron-related disorders. Nutrients 2013; 5:3034 - 61; http://dx.doi.org/10.3390/nu5083034; PMID: 23917168
   PubMed Web of Science ®Google Scholar
• Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho LP, Townsend AR, Drakesmith H. Hepcidin regulation by innate immune and infectious stimuli. Blood 2011; 118:4129 - 39; http://dx.doi.org/10.1182/blood-2011-04-351957; PMID: 21873546
   PubMed Web of Science ®Google Scholar
• MacKenzie EL, Iwasaki K, Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 2008; 10:997 - 1030; http://dx.doi.org/10.1089/ars.2007.1893; PMID: 18327971
   PubMed Web of Science ®Google Scholar
• Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H, Ishikawa I. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 2006; 108:1381 - 7; http://dx.doi.org/10.1182/blood-2005-10-4043; PMID: 16621968
   PubMed Web of Science ®Google Scholar
• Valore EV, Ganz T. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis 2008; 40:132 - 8; http://dx.doi.org/10.1016/j.bcmd.2007.07.009; PMID: 17905609
   PubMed Web of Science ®Google Scholar
• Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276:7806 - 10; http://dx.doi.org/10.1074/jbc.M008922200; PMID: 11113131
   PubMed Web of Science ®Google Scholar
• Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101:2461 - 3; http://dx.doi.org/10.1182/blood-2002-10-3235; PMID: 12433676
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005; 18:171 - 82; http://dx.doi.org/10.1016/j.beha.2004.08.020; PMID: 15737883
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090 - 3; http://dx.doi.org/10.1126/science.1104742; PMID: 15514116
   PubMed Web of Science ®Google Scholar
• Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110:1037 - 44; http://dx.doi.org/10.1172/JCI0215686; PMID: 12370282
   PubMed Web of Science ®Google Scholar
• Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med 2013; 19:850 - 8; http://dx.doi.org/10.1038/nm.3184; PMID: 23836235
   PubMed Web of Science ®Google Scholar
• Hoffman B, Liu Q. Hepatitis C viral protein translation: mechanisms and implications in developing antivirals. Liver Int 2011; 31:1449 - 67; http://dx.doi.org/10.1111/j.1478-3231.2011.02543.x; PMID: 21745290
   PubMed Web of Science ®Google Scholar
• Scheel TK, Rice CM. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med 2013; 19:837 - 49; http://dx.doi.org/10.1038/nm.3248; PMID: 23836234
   PubMed Web of Science ®Google Scholar
• Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 2007; 92:1037 - 42; http://dx.doi.org/10.3324/haematol.11281; PMID: 17640859
   PubMed Web of Science ®Google Scholar
• Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol 2007; 69:69 - 85; http://dx.doi.org/10.1146/annurev.physiol.69.031905.164337; PMID: 17014365
   PubMed Web of Science ®Google Scholar
• Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol 2008; 88:7 - 15; http://dx.doi.org/10.1007/s12185-008-0120-5; PMID: 18594779
   PubMed Web of Science ®Google Scholar
• Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000; 275:19906 - 12; http://dx.doi.org/10.1074/jbc.M000713200; PMID: 10747949
   PubMed Web of Science ®Google Scholar
• Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403:776 - 81; http://dx.doi.org/10.1038/35001596; PMID: 10693807
   PubMed Web of Science ®Google Scholar
• McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5:299 - 309; http://dx.doi.org/10.1016/S1097-2765(00)80425-6; PMID: 10882071
   PubMed Web of Science ®Google Scholar
• Marro S, Chiabrando D, Messana E, Stolte J, Turco E, Tolosano E, Muckenthaler MU. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica 2010; 95:1261 - 8; http://dx.doi.org/10.3324/haematol.2009.020123; PMID: 20179090
   PubMed Web of Science ®Google Scholar
• Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, Beaumont C. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 2011; 140:1261 - 71, e1; http://dx.doi.org/10.1053/j.gastro.2010.12.037; PMID: 21199652
   PubMed Web of Science ®Google Scholar
• Franchini M, Montagnana M, Lippi G. Hepcidin and iron metabolism: from laboratory to clinical implications. Clin Chim Acta 2010; 411:1565 - 9; http://dx.doi.org/10.1016/j.cca.2010.07.003; PMID: 20620132
   PubMed Web of Science ®Google Scholar
• Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab 2009; 9:217 - 27; http://dx.doi.org/10.1016/j.cmet.2009.01.010; PMID: 19254567
   PubMed Web of Science ®Google Scholar
• Wang RH, Li C, Xu X, Zheng Y, Xiao C, Zerfas P, Cooperman S, Eckhaus M, Rouault T, Mishra L, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005; 2:399 - 409; http://dx.doi.org/10.1016/j.cmet.2005.10.010; PMID: 16330325
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117:4425 - 33; http://dx.doi.org/10.1182/blood-2011-01-258467; PMID: 21346250
   PubMed Web of Science ®Google Scholar
• Castoldi M, Muckenthaler MU. Regulation of iron homeostasis by microRNAs. Cell Mol Life Sci 2012; 2012:9; PMID: 22678662
   PubMed Web of Science ®Google Scholar
• Zumbrennen-Bullough KWQ, Chen W, Babitt J. MicroRNA-130a Downregulates Hepcidin Expression during Iron Deficiency by Targeting ALK2. Proceedings of Fifth Congress of the International BioIron Society (IBIS), Biennial World Meeting (BioIron 2013); London, UK 14–18 April 2013 2013.
   Google Scholar
• Zhang X, Rovin BH. Beyond anemia: hepcidin, monocytes and inflammation. Biol Chem 2013; 394:231 - 8; http://dx.doi.org/10.1515/bchm-2012-0217; PMID: 23314535
   PubMed Web of Science ®Google Scholar
• Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002; 99:3505 - 16; http://dx.doi.org/10.1182/blood.V99.10.3505; PMID: 11986201
   PubMed Web of Science ®Google Scholar
• Cairo G, Recalcati S. Iron-regulatory proteins: molecular biology and pathophysiological implications. Expert Rev Mol Med 2007; 9:1 - 13; http://dx.doi.org/10.1017/S1462399407000531; PMID: 18053288
   PubMedGoogle Scholar
• Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011; 434:365 - 81; http://dx.doi.org/10.1042/BJ20101825; PMID: 21348856
   PubMed Web of Science ®Google Scholar
• Muckenthaler MU. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab 2008; 8:1 - 3; http://dx.doi.org/10.1016/j.cmet.2008.06.009; PMID: 18590684
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis 1996; 16:13 - 30; http://dx.doi.org/10.1055/s-2007-1007215; PMID: 8723320
   PubMed Web of Science ®Google Scholar
• Videla LA, Fernández V, Tapia G, Varela P. Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals 2003; 16:103 - 11; http://dx.doi.org/10.1023/A:1020707811707; PMID: 12572670
   PubMed Web of Science ®Google Scholar
• Braliou GG, Verga Falzacappa MV, Chachami G, Casanovas G, Muckenthaler MU, Simos G. 2-Oxoglutarate-dependent oxygenases control hepcidin gene expression. J Hepatol 2008; 48:801 - 10; http://dx.doi.org/10.1016/j.jhep.2007.12.021; PMID: 18313788
   PubMed Web of Science ®Google Scholar
• Chaston TB, Matak P, Pourvali K, Srai SK, McKie AT, Sharp PA. Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling. Am J Physiol Cell Physiol 2011; 300:C888 - 95; http://dx.doi.org/10.1152/ajpcell.00121.2010; PMID: 21289291
   PubMedGoogle Scholar
• Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol 2007; 13:4755 - 60; PMID: 17729397
   PubMed Web of Science ®Google Scholar
• Ko C, Siddaiah N, Berger J, Gish R, Brandhagen D, Sterling RK, Cotler SJ, Fontana RJ, McCashland TM, Han SH, et al. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int 2007; 27:1394 - 401; http://dx.doi.org/10.1111/j.1478-3231.2007.01596.x; PMID: 17927713
   PubMed Web of Science ®Google Scholar
• Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, Kobayashi Y, Iwasa M, Watanabe S, Adachi Y, et al. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med 2007; 13:97 - 104; http://dx.doi.org/10.2119/2006-00057.Fujita; PMID: 17515961
   PubMed Web of Science ®Google Scholar
• Sikorska K, Stalke P, Izycka-Swieszewska E, Romanowski T, Bielawski KP. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C. Med Sci Monit 2010; 16:CR137 - 43; PMID: 20190684
   PubMedGoogle Scholar
• Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol 2008; 6:541 - 52; http://dx.doi.org/10.1038/nrmicro1930; PMID: 18552864
   PubMed Web of Science ®Google Scholar
• Maliken BD, Nelson JE, Kowdley KV. The hepcidin circuits act: balancing iron and inflammation. Hepatology 2011; 53:1764 - 6; http://dx.doi.org/10.1002/hep.24267; PMID: 21520181
   PubMedGoogle Scholar
• De Domenico I, Ward DM, Kaplan J. Hepcidin regulation: ironing out the details. J Clin Invest 2007; 117:1755 - 8; http://dx.doi.org/10.1172/JCI32701; PMID: 17607352
   PubMed Web of Science ®Google Scholar
• Poli M, Luscieti S, Gandini V, Maccarinelli F, Finazzi D, Silvestri L, Roetto A, Arosio P. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica 2010; 95:1832 - 40; http://dx.doi.org/10.3324/haematol.2010.027003; PMID: 20634490
   PubMed Web of Science ®Google Scholar
• Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, et al. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology 2000; 31:730 - 6; http://dx.doi.org/10.1002/hep.510310325; PMID: 10706565
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, et al, HALT-C Trial Group. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology 2006; 131:1440 - 51; http://dx.doi.org/10.1053/j.gastro.2006.08.036; PMID: 17101320
   PubMed Web of Science ®Google Scholar
• Meynard D, Babitt JL, Lin HY. The liver: conductor of systemic iron balance. Blood 2014; 123:168 - 76; http://dx.doi.org/10.1182/blood-2013-06-427757; PMID: 24200681
   PubMed Web of Science ®Google Scholar
• Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994; 19:222 - 6; http://dx.doi.org/10.1097/00004836-199410000-00011; PMID: 7528758
   PubMed Web of Science ®Google Scholar
• Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN. HCV and oxidative stress in the liver. Viruses 2013; 5:439 - 69; http://dx.doi.org/10.3390/v5020439; PMID: 23358390
   PubMed Web of Science ®Google Scholar
• Buratti E, Tisminetzky S, Zotti M, Baralle FE. Functional analysis of the interaction between HCV 5’UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res 1998; 26:3179 - 87; http://dx.doi.org/10.1093/nar/26.13.3179; PMID: 9628916
   PubMed Web of Science ®Google Scholar
• Cho H, Lee HC, Jang SK, Kim YK. Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus. Virus Genes 2008; 37:154 - 60; http://dx.doi.org/10.1007/s11262-008-0250-0; PMID: 18566883
   PubMed Web of Science ®Google Scholar
• Kieft JS, Zhou K, Jubin R, Doudna JA. Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA 2001; 7:194 - 206; http://dx.doi.org/10.1017/S1355838201001790; PMID: 11233977
   PubMed Web of Science ®Google Scholar
• Theurl I, Zoller H, Obrist P, Datz C, Bachmann F, Elliott RM, Weiss G. Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. J Infect Dis 2004; 190:819 - 25; http://dx.doi.org/10.1086/422261; PMID: 15272411
   PubMed Web of Science ®Google Scholar
• Johnson KR, Merrick WC, Zoll WL, Zhu Y. Identification of cDNA clones for the large subunit of eukaryotic translation initiation factor 3. Comparison of homologues from human, Nicotiana tabacum, Caenorhabditis elegans, and Saccharomyces cerevisiae. J Biol Chem 1997; 272:7106 - 13; http://dx.doi.org/10.1074/jbc.272.11.7106; PMID: 9054404
   PubMed Web of Science ®Google Scholar
• Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Noguchi O, Miyake S, Nouchi T, Fujisawa K, Marumo F, et al. Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus. Dig Dis Sci 1996; 41:989 - 94; http://dx.doi.org/10.1007/BF02091542; PMID: 8625774
   PubMed Web of Science ®Google Scholar
• Liu Y, An D, Sun R, Jin L, Wang Q. Inhibition of translation initiation factors might be the potential therapeutic targets for HCV patients with hepatic iron overload. Med Hypotheses 2012; 78:142 - 3; http://dx.doi.org/10.1016/j.mehy.2011.10.011; PMID: 22047986
   PubMed Web of Science ®Google Scholar
• Bartolomei G, Cevik RE, Marcello A. Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes. J Gen Virol 2011; 92:2072 - 81; http://dx.doi.org/10.1099/vir.0.032706-0; PMID: 21593278
   PubMed Web of Science ®Google Scholar
• Fillebeen C, Pantopoulos K. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. J Hepatol 2010; 53:995 - 9; http://dx.doi.org/10.1016/j.jhep.2010.04.044; PMID: 20813419
   PubMed Web of Science ®Google Scholar
• Fillebeen C, Rivas-Estilla AM, Bisaillon M, Ponka P, Muckenthaler M, Hentze MW, Koromilas AE, Pantopoulos K. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus. J Biol Chem 2005; 280:9049 - 57; http://dx.doi.org/10.1074/jbc.M412687200; PMID: 15637067
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Hemochromatosis gene modifies course of hepatitis C viral infection. Gastroenterology 2003; 124:1509 - 23; http://dx.doi.org/10.1016/S0016-5085(03)00275-0; PMID: 12730889
   PubMed Web of Science ®Google Scholar
• Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 2003; 124:318 - 26; http://dx.doi.org/10.1053/gast.2003.50046; PMID: 12557137
   PubMed Web of Science ®Google Scholar
• Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, Furutani T, Sakai A, Okuda M, Hidaka I, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008; 134:226 - 38; http://dx.doi.org/10.1053/j.gastro.2007.10.011; PMID: 18166355
   PubMed Web of Science ®Google Scholar
• Moriya K, Miyoshi H, Shinzawa S, Tsutsumi T, Fujie H, Goto K, Shintani Y, Yotsuyanagi H, Koike K. Hepatitis C virus core protein compromises iron-induced activation of antioxidants in mice and HepG2 cells. J Med Virol 2010; 82:776 - 92; http://dx.doi.org/10.1002/jmv.21661; PMID: 20336713
   PubMed Web of Science ®Google Scholar
• Choi SO, Cho YS, Kim HL, Park JW. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem Biophys Res Commun 2007; 356:312 - 7; http://dx.doi.org/10.1016/j.bbrc.2007.02.137; PMID: 17349976
   PubMed Web of Science ®Google Scholar
• Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008; 48:1420 - 9; http://dx.doi.org/10.1002/hep.22486; PMID: 18671304
   PubMed Web of Science ®Google Scholar
• Nagashima M, Kudo M, Chung H, Ishikawa E, Hagiwara S, Nakatani T, Dote K. Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 2006; 36:288 - 93; http://dx.doi.org/10.1016/j.hepres.2006.08.006; PMID: 16979376
   PubMed Web of Science ®Google Scholar
• Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007; 109:353 - 8; http://dx.doi.org/10.1182/blood-2006-07-033969; PMID: 16946298
   PubMed Web of Science ®Google Scholar
• Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006; 108:3204 - 9; http://dx.doi.org/10.1182/blood-2006-06-027631; PMID: 16835372
   PubMed Web of Science ®Google Scholar
• Miyachi H, Kobayashi Y, Relja B, Fujita N, Iwasa M, Gabazza EC, Takei Y. Effect of suppressor of cytokine signaling on hepcidin production in hepatitis C virus replicon cells. Hepatol Res 2011; 41:364 - 74; http://dx.doi.org/10.1111/j.1872-034X.2011.00777.x; PMID: 21348906
   PubMed Web of Science ®Google Scholar
• Fillebeen C, Muckenthaler M, Andriopoulos B, Bisaillon M, Mounir Z, Hentze MW, Koromilas AE, Pantopoulos K. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol 2007; 47:12 - 22; http://dx.doi.org/10.1016/j.jhep.2007.01.035; PMID: 17399844
   PubMed Web of Science ®Google Scholar
• Kanda T, Yokosuka O, Omata M, Hepatitis C. Virus and Hepatocellular Carcinoma. Biology 2013; 2:304 - 16; http://dx.doi.org/10.3390/biology2010304
   Google Scholar
• Fukutomi T, Zhou Y, Kawai S, Eguchi H, Wands JR, Li J. Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. Hepatology 2005; 41:1096 - 105; http://dx.doi.org/10.1002/hep.20668; PMID: 15841445
   PubMed Web of Science ®Google Scholar
• Kochlios E, Foka P, Tsitoura E, Doumba P, Koskinas J, Mavromara P. Effect of HCV core and core+1/S on pro- and anti-inflammatory cytokine and chemokine gene expression. Bologna, Italy: Medimond SRL Publ., 2010.
   Google Scholar
• Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem 2011; 286:10847 - 55; http://dx.doi.org/10.1074/jbc.M110.217653; PMID: 21282107
   PubMed Web of Science ®Google Scholar
• Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M, Yoshimura A. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 2002; 196:641 - 53; http://dx.doi.org/10.1084/jem.20012127; PMID: 12208879
   PubMed Web of Science ®Google Scholar
• Cozza G, Mazzorana M, Papinutto E, Bain J, Elliott M, di Maira G, Gianoncelli A, Pagano MA, Sarno S, Ruzzene M, et al. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. Biochem J 2009; 421:387 - 95; http://dx.doi.org/10.1042/BJ20090069; PMID: 19432557
   PubMed Web of Science ®Google Scholar
• Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV, Chung RT. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 2005; 128:1034 - 41; http://dx.doi.org/10.1053/j.gastro.2005.02.006; PMID: 15825084
   PubMed Web of Science ®Google Scholar
• Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y, Omata M. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol 2004; 72:52 - 9; http://dx.doi.org/10.1002/jmv.10545; PMID: 14635011
   PubMed Web of Science ®Google Scholar
• Pavio N, Battaglia S, Boucreux D, Arnulf B, Sobesky R, Hermine O, Brechot C. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. Oncogene 2005; 24:6119 - 32; http://dx.doi.org/10.1038/sj.onc.1208749; PMID: 16007207
   PubMed Web of Science ®Google Scholar
• Battaglia S, Benzoubir N, Nobilet S, Charneau P, Samuel D, Zignego AL, Atfi A, Bréchot C, Bourgeade MF. Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 2009; 4:e4355; http://dx.doi.org/10.1371/journal.pone.0004355; PMID: 19190755
   PubMedGoogle Scholar
• Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H, Matsuura Y, Koike K, Miyamura T. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 2003; 38:820 - 8; http://dx.doi.org/10.1002/hep.1840380408; PMID: 14512869
   PubMed Web of Science ®Google Scholar
• Serti E, Doumba PP, Thyphronitis G, Tsitoura P, Katsarou K, Foka P, Konstandoulakis MM, Koskinas J, Mavromara P, Georgopoulou U. Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cell Mol Life Sci 2011; 68:505 - 22; http://dx.doi.org/10.1007/s00018-010-0466-8; PMID: 20680391
   PubMed Web of Science ®Google Scholar
• Hayashi J, Aoki H, Kajino K, Moriyama M, Arakawa Y, Hino O. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology 2000; 32:958 - 61; http://dx.doi.org/10.1053/jhep.2000.19343; PMID: 11050045
   PubMed Web of Science ®Google Scholar
• Aoyagi K, Ohue C, Iida K, Kimura T, Tanaka E, Kiyosawa K, Yagi S. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999; 37:1802 - 8; PMID: 10325327
   PubMed Web of Science ®Google Scholar
• Katsarou K, Lavdas AA, Tsitoura P, Serti E, Markoulatos P, Mavromara P, Georgopoulou U. Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events. Cell Mol Life Sci 2010; 67:2491 - 506; http://dx.doi.org/10.1007/s00018-010-0351-5; PMID: 20358251
   PubMed Web of Science ®Google Scholar
• Zhao LJ, Wang L, Ren H, Cao J, Li L, Ke JS, Qi ZT. Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Exp Cell Res 2005; 305:23 - 32; http://dx.doi.org/10.1016/j.yexcr.2004.12.024; PMID: 15777784
   PubMed Web of Science ®Google Scholar
• Zhao LJ, Zhao P, Chen QL, Ren H, Pan W, Qi ZT. Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection. Cell Prolif 2007; 40:508 - 21; http://dx.doi.org/10.1111/j.1365-2184.2007.00453.x; PMID: 17635518
   PubMed Web of Science ®Google Scholar
• Hassan M, Ghozlan H, Abdel-Kader O. Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 2005; 333:324 - 36; http://dx.doi.org/10.1016/j.virol.2005.01.008; PMID: 15721365
   PubMed Web of Science ®Google Scholar
• Feng DY, Sun Y, Cheng RX, Ouyang XM, Zheng H. Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line. World J Gastroenterol 2005; 11:2157 - 61; PMID: 15810084
   PubMed Web of Science ®Google Scholar
• Pei R, Chen H, Lu L, Zhu W, Beckebaum S, Cicinnati V, Lu M, Chen X. Hepatitis C virus infection induces the expression of amphiregulin, a factor related to the activation of cellular survival pathways and required for efficient viral assembly. J Gen Virol 2011; 92:2237 - 48; http://dx.doi.org/10.1099/vir.0.032581-0; PMID: 21653755
   PubMed Web of Science ®Google Scholar
• Verga-Gérard A, Porcherot M, Meyniel-Schicklin L, André P, Lotteau V, Perrin-Cocon L. Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF-β signaling. FASEB J 2013; 27:4027 - 40; http://dx.doi.org/10.1096/fj.13-229187; PMID: 23781096
   PubMed Web of Science ®Google Scholar
• Weizer-Stern O, Adamsky K, Margalit O, Ashur-Fabian O, Givol D, Amariglio N, Rechavi G. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53. Br J Haematol 2007; 138:253 - 62; http://dx.doi.org/10.1111/j.1365-2141.2007.06638.x; PMID: 17593032
   PubMed Web of Science ®Google Scholar
• Sarcar B, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology 2004; 322:51 - 60; http://dx.doi.org/10.1016/j.virol.2004.01.008; PMID: 15063116
   PubMed Web of Science ®Google Scholar
• Presser LD, Haskett A, Waris G. Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-β1: role of TGF-β1 in HCV replication. Virology 2011; 412:284 - 96; http://dx.doi.org/10.1016/j.virol.2010.12.051; PMID: 21296375
   PubMed Web of Science ®Google Scholar
• Choi SH, Hwang SB. Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein. J Biol Chem 2006; 281:7468 - 78; http://dx.doi.org/10.1074/jbc.M512438200; PMID: 16407286
   PubMed Web of Science ®Google Scholar
• Macdonald A, Crowder K, Street A, McCormick C, Saksela K, Harris M. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J Biol Chem 2003; 278:17775 - 84; http://dx.doi.org/10.1074/jbc.M210900200; PMID: 12621033
   PubMed Web of Science ®Google Scholar
• Georgopoulou U, Caravokiri K, Mavromara P. Suppression of the ERK1/2 signaling pathway from HCV NS5A protein expressed by herpes simplex recombinant viruses. Arch Virol 2003; 148:237 - 51; http://dx.doi.org/10.1007/s00705-002-0925-0; PMID: 12556990
   PubMed Web of Science ®Google Scholar
• Nelson JE, Klintworth H, Kowdley KV. Iron metabolism in Nonalcoholic Fatty Liver Disease. Curr Gastroenterol Rep 2012; 14:8 - 16; http://dx.doi.org/10.1007/s11894-011-0234-4; PMID: 22124850
   PubMedGoogle Scholar
• Aso Y, Wakabayashi S, Yamamoto R, Matsutomo R, Takebayashi K, Inukai T. Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor. Diabetes Care 2005; 28:2211 - 6; http://dx.doi.org/10.2337/diacare.28.9.2211; PMID: 16123492
   PubMed Web of Science ®Google Scholar
• Younossi ZM, McCullough AJ. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. Liver Int 2009; 29:Suppl 2 3 - 12; http://dx.doi.org/10.1111/j.1478-3231.2008.01949.x; PMID: 19187068
   PubMedGoogle Scholar
• Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007; 9:1089 - 97; http://dx.doi.org/10.1038/ncb1631; PMID: 17721513
   PubMed Web of Science ®Google Scholar
• Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, Murata S, Tanaka K, Miyamura T, Suzuki T, et al. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A 2007; 104:1661 - 6; http://dx.doi.org/10.1073/pnas.0607312104; PMID: 17234812
   PubMed Web of Science ®Google Scholar
• Björnsson E, Angulo P. Hepatitis C and steatosis. Arch Med Res 2007; 38:621 - 7; http://dx.doi.org/10.1016/j.arcmed.2006.09.001; PMID: 17613353
   PubMed Web of Science ®Google Scholar
• Roe B, Kensicki E, Mohney R, Hall WW. Metabolomic profile of hepatitis C virus-infected hepatocytes. PLoS One 2011; 6:e23641; http://dx.doi.org/10.1371/journal.pone.0023641; PMID: 21853158
   PubMed Web of Science ®Google Scholar
• Roingeard P, Hourioux C. Hepatitis C virus core protein, lipid droplets and steatosis. J Viral Hepat 2008; 15:157 - 64; http://dx.doi.org/10.1111/j.1365-2893.2007.00953.x; PMID: 18086178
   PubMed Web of Science ®Google Scholar
• Koike K, Moriya K, Matsuura Y. Animal models for hepatitis C and related liver disease. Hepatol Res 2010; 40:69 - 82; http://dx.doi.org/10.1111/j.1872-034X.2009.00593.x; PMID: 20156300
   PubMed Web of Science ®Google Scholar
• Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, Miyanishi K, Kobune M, Sato Y, Takayama T, Matunaga T, et al. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut 2006; 55:1801 - 8; http://dx.doi.org/10.1136/gut.2005.070417; PMID: 16581947
   PubMed Web of Science ®Google Scholar
• Gómez-Gonzalo M, Benedicto I, Carretero M, Lara-Pezzi E, Maldonado-Rodríguez A, Moreno-Otero R, Lai MM, López-Cabrera M. Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity. Virology 2004; 328:120 - 30; http://dx.doi.org/10.1016/j.virol.2004.06.044; PMID: 15380363
   PubMed Web of Science ®Google Scholar
• Tsutsumi T, Suzuki T, Shimoike T, Suzuki R, Moriya K, Shintani Y, Fujie H, Matsuura Y, Koike K, Miyamura T. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology 2002; 35:937 - 46; http://dx.doi.org/10.1053/jhep.2002.32470; PMID: 11915042
   PubMed Web of Science ®Google Scholar
• Waris G, Felmlee DJ, Negro F, Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 2007; 81:8122 - 30; http://dx.doi.org/10.1128/JVI.00125-07; PMID: 17507484
   PubMed Web of Science ®Google Scholar
• García-Mediavilla MV, Pisonero-Vaquero S, Lima-Cabello E, Benedicto I, Majano PL, Jorquera F, González-Gallego J, Sánchez-Campos S. Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication. Lab Invest 2012; 92:1191 - 202; http://dx.doi.org/10.1038/labinvest.2012.88; PMID: 22641099
   PubMed Web of Science ®Google Scholar
• Dharancy S, Malapel M, Perlemuter G, Roskams T, Cheng Y, Dubuquoy L, Podevin P, Conti F, Canva V, Philippe D, et al. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 2005; 128:334 - 42; http://dx.doi.org/10.1053/j.gastro.2004.11.016; PMID: 15685545
   PubMed Web of Science ®Google Scholar
• Kim K, Kim KH, Ha E, Park JY, Sakamoto N, Cheong J. Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma. FEBS Lett 2009; 583:2720 - 6; http://dx.doi.org/10.1016/j.febslet.2009.07.034; PMID: 19631645
   PubMed Web of Science ®Google Scholar
• Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 2007; 355:883 - 8; http://dx.doi.org/10.1016/j.bbrc.2007.02.044; PMID: 17331464
   PubMed Web of Science ®Google Scholar
• Foka P, Karamichali E, Dalagiorgou G, Serti E, Doumba PP, Pissas G, Kakkanas A, Kazazi D, Kochlios E, Gaitanou M, et al. Hepatitis C virus modulates lipid regulatory factor Angiopoietin-like 3 gene expression by repressing HNF-1alpha activity. J Hepatol 2014; 60:30 - 8; http://dx.doi.org/10.1016/j.jhep.2013.08.016; PMID: 23978712
   PubMed Web of Science ®Google Scholar
• Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol 2011; 55:920 - 32; http://dx.doi.org/10.1016/j.jhep.2011.05.008; PMID: 21718726
   PubMed Web of Science ®Google Scholar
• Wlazlo N, Greevenbroek MM. Lipid metabolism: a role for iron?. Curr Opin Lipidol 2012; 23:258 - 9; http://dx.doi.org/10.1097/MOL.0b013e328354752d; PMID: 22576585
   PubMed Web of Science ®Google Scholar
• Haap M, Machann J, von Friedeburg C, Schick F, Stefan N, Schwenzer NF, Fritsche A, Häring HU, Thamer C. Insulin sensitivity and liver fat: role of iron load. J Clin Endocrinol Metab 2011; 96:E958 - 61; http://dx.doi.org/10.1210/jc.2010-2682; PMID: 21430023
   PubMedGoogle Scholar
• Ahmed U, Latham PS, Oates PS. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. World J Gastroenterol 2012; 18:4651 - 8; http://dx.doi.org/10.3748/wjg.v18.i34.4651; PMID: 23002334
   PubMed Web of Science ®Google Scholar
• Choi JS, Koh IU, Lee HJ, Kim WH, Song J. Effects of excess dietary iron and fat on glucose and lipid metabolism. J Nutr Biochem 2013; 24:1634 - 44; http://dx.doi.org/10.1016/j.jnutbio.2013.02.004; PMID: 23643521
   PubMed Web of Science ®Google Scholar
• Lewis M, Iammarino RM. Lipemia in rodent iron-deficiency anemia. J Lab Clin Med 1971; 78:546 - 54; PMID: 5114051
   PubMedGoogle Scholar
• Sherman AR. Lipogenesis in iron-deficient adult rats. Lipids 1978; 13:473 - 8; http://dx.doi.org/10.1007/BF02533616; PMID: 692295
   PubMed Web of Science ®Google Scholar
• Tosco A, Fontanella B, Danise R, Cicatiello L, Grober OM, Ravo M, Weisz A, Marzullo L. Molecular bases of copper and iron deficiency-associated dyslipidemia: a microarray analysis of the rat intestinal transcriptome. Genes Nutr 2010; 5:1 - 8; http://dx.doi.org/10.1007/s12263-009-0153-2; PMID: 19821111
   PubMed Web of Science ®Google Scholar
• Stangl GI, Kirchgessner M. Different degrees of moderate iron deficiency modulate lipid metabolism of rats. Lipids 1998; 33:889 - 95; http://dx.doi.org/10.1007/s11745-998-0285-8; PMID: 9778136
   PubMed Web of Science ®Google Scholar
• Rao GA, Crane RT, Larkin EC. Reduced plasma lecithin cholesterol acyl transferase activity in rats fed iron-deficient diets. Lipids 1983; 18:673 - 6; http://dx.doi.org/10.1007/BF02534575; PMID: 6656532
   PubMed Web of Science ®Google Scholar
• Bacon BR, Britton RS, O’Neill R. Effects of vitamin E deficiency on hepatic mitochondrial lipid peroxidation and oxidative metabolism in rats with chronic dietary iron overload. Hepatology 1989; 9:398 - 404; http://dx.doi.org/10.1002/hep.1840090309; PMID: 2920996
   PubMed Web of Science ®Google Scholar
• Feldman ES, Bacon BR. Hepatic mitochondrial oxidative metabolism and lipid peroxidation in experimental hexachlorobenzene-induced porphyria with dietary carbonyl iron overload. Hepatology 1989; 9:686 - 92; http://dx.doi.org/10.1002/hep.1840090505; PMID: 2707735
   PubMed Web of Science ®Google Scholar
• Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997; 26:584 - 92; http://dx.doi.org/10.1016/S0168-8278(97)80424-2; PMID: 9075666
   PubMed Web of Science ®Google Scholar
• Bories G, Colin S, Vanhoutte J, Derudas B, Copin C, Fanchon M, Daoudi M, Belloy L, Haulon S, Zawadzki C, et al. Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res 2013; 113:1196 - 205; http://dx.doi.org/10.1161/CIRCRESAHA.113.301656; PMID: 24036496
   PubMed Web of Science ®Google Scholar
• Bonomo LdeF, Silva M, Oliveira RdeP, Silva ME, Pedrosa ML. Iron overload potentiates diet-induced hypercholesterolemia and reduces liver PPAR-α expression in hamsters. J Biochem Mol Toxicol 2012; 26:224 - 9; http://dx.doi.org/10.1002/jbt.21410; PMID: 22570273
   PubMed Web of Science ®Google Scholar
• Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995; 22:449 - 56; http://dx.doi.org/10.1016/0168-8278(95)80108-1; PMID: 7545199
   PubMed Web of Science ®Google Scholar
• Kageyama F, Kobayashi Y, Kawasaki T, Toyokuni S, Uchida K, Nakamura H. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000; 95:1041 - 50; http://dx.doi.org/10.1111/j.1572-0241.2000.01979.x; PMID: 10763957
   PubMed Web of Science ®Google Scholar
• Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, Sumida Y, Nakagawa N, Kojima Y, Watanabe S, Adachi Y, et al. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol 2006; 21:1821 - 5; http://dx.doi.org/10.1111/j.1440-1746.2006.04420.x; PMID: 17074020
   PubMed Web of Science ®Google Scholar
• Barisani D, Pelucchi S, Mariani R, Galimberti S, Trombini P, Fumagalli D, Meneveri R, Nemeth E, Ganz T, Piperno A. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. J Hepatol 2008; 49:123 - 33; http://dx.doi.org/10.1016/j.jhep.2008.03.011; PMID: 18462824
   PubMed Web of Science ®Google Scholar
• Hézode C, Cazeneuve C, Coué O, Roudot-Thoraval F, Lonjon I, Bastie A, Duvoux C, Pawlotsky JM, Zafrani ES, Amselem S, et al. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol 1999; 31:979 - 84; http://dx.doi.org/10.1016/S0168-8278(99)80308-0; PMID: 10604569
   PubMed Web of Science ®Google Scholar
• Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, et al, HALT-C Trial Group. Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology 2009; 49:1828 - 37; http://dx.doi.org/10.1002/hep.22865; PMID: 19291787
   PubMed Web of Science ®Google Scholar
• Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S, Orlando E, Petta S. Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int 2013; 2013:564645; http://dx.doi.org/10.1155/2013/564645; PMID: 23956991
   PubMed Web of Science ®Google Scholar
• Hino K, Nishina S, Hara Y. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis. J Gastroenterol Hepatol 2013; 28:Suppl 4 93 - 8; http://dx.doi.org/10.1111/jgh.12243; PMID: 24251712
   PubMedGoogle Scholar
• Adinolfi LE, Durante-Mangoni E, Zampino R, Ruggiero G. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications. Aliment Pharmacol Ther 2005; 22:Suppl 2 52 - 5; http://dx.doi.org/10.1111/j.1365-2036.2005.02597.x; PMID: 16225474
   PubMedGoogle Scholar
• Mueller S, Afdhal NH, Schuppan D. Iron, HCV, and liver cancer: hard metal setting the pace?. Gastroenterology 2006; 130:2229 - 34; http://dx.doi.org/10.1053/j.gastro.2006.05.006; PMID: 16762645
   PubMed Web of Science ®Google Scholar
• Ward DG, Roberts K, Brookes MJ, Joy H, Martin A, Ismail T, Spychal R, Iqbal T, Tselepis C. Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol 2008; 14:1339 - 45; http://dx.doi.org/10.3748/wjg.14.1339; PMID: 18322945
   PubMed Web of Science ®Google Scholar
• Piperno A, Mariani R, Trombini P, Girelli D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol 2009; 15:538 - 51; http://dx.doi.org/10.3748/wjg.15.538; PMID: 19195055
   PubMed Web of Science ®Google Scholar
• Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, Mamalaki A, Archimandritis AJ. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat 2010; 17:800 - 6; http://dx.doi.org/10.1111/j.1365-2893.2009.01244.x; PMID: 20002304
   PubMed Web of Science ®Google Scholar
• Mitsuyoshi H, Yasui K, Yamaguchi K, Minami M, Okanoue T, Itoh Y. Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C. Int J Hepatol 2013; 2013:686420; http://dx.doi.org/10.1155/2013/686420; PMID: 23653861
   PubMedGoogle Scholar
• Pietrangelo A, Montosi G, Garuti C, Contri M, Giovannini F, Ceccarelli D, Masini A. Iron-induced oxidant stress in nonparenchymal liver cells: mitochondrial derangement and fibrosis in acutely iron-dosed gerbils and its prevention by silybin. J Bioenerg Biomembr 2002; 34:67 - 79; http://dx.doi.org/10.1023/A:1013874804911; PMID: 11860182
   PubMed Web of Science ®Google Scholar
• Nelson JE, Wilson L, Brunt EM, Yeh MM, Kleiner DE, Unalp-Arida A, Kowdley KV, Nonalcoholic Steatohepatitis Clinical Research Network. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 2011; 53:448 - 57; http://dx.doi.org/10.1002/hep.24038; PMID: 21274866
   PubMed Web of Science ®Google Scholar
• Nieto N, Friedman SL, Greenwel P, Cederbaum AI. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 1999; 30:987 - 96; http://dx.doi.org/10.1002/hep.510300433; PMID: 10498651
   PubMed Web of Science ®Google Scholar
• Jaroszewicz J, Rogalska M, Flisiak I, Flisiak R. Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C. World J Gastroenterol 2010; 16:1747 - 52; http://dx.doi.org/10.3748/wjg.v16.i14.1747; PMID: 20380007
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. J Viral Hepat 2006; 13:199 - 205; http://dx.doi.org/10.1111/j.1365-2893.2005.00662.x; PMID: 16475996
   PubMed Web of Science ®Google Scholar
• Hourioux C, Patient R, Morin A, Blanchard E, Moreau A, Trassard S, Giraudeau B, Roingeard P. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut 2007; 56:1302 - 8; http://dx.doi.org/10.1136/gut.2006.108647; PMID: 17213339
   PubMed Web of Science ®Google Scholar
• Ryan JD, Altamura S, Devitt E, Mullins S, Lawless MW, Muckenthaler MU, Crowe J. Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C. Hepatology 2012; 56:492 - 500; http://dx.doi.org/10.1002/hep.25666; PMID: 22334511
   PubMed Web of Science ®Google Scholar